Update on the diagnosis and treatment of menopause syndrome
10.3760/cma.j.issn.1008-6706.2017.23.040
- VernacularTitle:围绝经期综合征的诊治进展
- Author:
Lin CAO
1
;
Hongping SUN
;
Rendong ZHENG
;
Wen CAO
;
Juan XU
;
Chao LIU
Author Information
1. 南京中医药大学附属中西医结合医院江苏省中医药研究院内分泌科
- Keywords:
Menopause syndrome;
Vasomotor symptoms;
Menopausal hormone therapy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(23):3668-3671
- CountryChina
- Language:Chinese
-
Abstract:
With the advance of medicine and the extension of life expectancy,the proportion of elderly people is increasing around the world,so is the postmenopausal women in the world~ population.More and more women will be bothered by various perimenopausal problems.Vasomotor symptoms(VMS) and the genitourinary syndrome of menopause(GSM) are recognized as the most frequent symptoms associated with menopause.Menopausal hormone therapy (MHT) is the most effective intervention for management of these symptoms.However,the role of MHT in the prevention of cardiovascular disease,skeleton,urogenital systems remains controversial.New drugs such as selective estrogen receptor modulators are equivalent to MHT on the relief of VMS.In addition,it can also prevent bone loss,becoming a new research highlights.Nonhormonal management is an important consideration when hormone therapy is not an option because of medical contraindications or a woman's personal choice,like lifestyle changes,selective serotonin reuptake inhibitors,serotonin-norepinephrine reuptake inhibitors,vaginal laser and etc.
